The DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index.
False leukemia–lymphoma cell lines: an update on over 500 cell lines
Abstract
Human leukemia-lymphoma (LL) cell lines represent an extremely important resource for research in a variety of fields and disciplines. As the cell lines are used as in vitro model systems in lieu of primary cell material, it is crucial that the cells in the culture flasks faithfully correspond to the purported objects of study. Obviously, proper authentication of cell line derivation and precise characterization are indispensable requirements to use as model systems. A number of studies has shown an unacceptable level of LL cell lines to be false. We present here the results of authenticating a comprehensively large sample (n = 550) of LL cell lines mainly by DNA fingerprinting and cytogenetic evaluation. Surprisingly, near-identical incidences (ca 15%) of false cell lines were observed among cell lines obtained directly from original investigators (59/395: 14.9%) and from secondary sources (23/155: 14.8%) implying that most cross-contamination is perpetrated by originators, presumably during establishment. By comparing our data with those published, we were further able to subclassify the false cell lines as (1) virtual: cross-contaminated with and unretrievably overgrown by other cell lines during initiation, never enjoying independent existence; (2) misidentified: cross-contaminated subsequent to establishment so that an original prototype may still exist; or (3) misclassified: unwittingly established from an unintended (often normal) cell type. Prolific classic leukemia c…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the issue of misidentified cell lines has long been known, its effect on the scientific literature has not been properly recognised, let alone properly treated [47, 48].”
From The ghosts of HeLa: How cell line misidentification contaminates the scientific literature (2017) · cites this paper as [47]
In the citing paper
“In 2003, Drexler, et al. fingerprinted 550 leukemia-lymphoma cells and calculated a 29.7%rate of CCCM [82].”
From The history, landscape, and outlook of human cell line authentication and security (2024) · cites this paper as [82]
Citations
Cites
Hypervariable ‘minisatellite’ regions in human DNA
Jeffreys, A. J., Wilson, V., & Thein, S. L. (1985) · Nature · doi:10.1038/314067a0 · Cited by 3,771
Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)
Sundström, C., & Nilsson, K. (1976) · International Journal of Cancer · doi:10.1002/ijc.2910170504 · Cited by 2,409
Individual-specific ‘fingerprints’ of human DNA
Jeffreys, A. J., Wilson, V., & Thein, S. L. (1985) · Nature · doi:10.1038/316076a0 · Cited by 2,172
Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture
Collins, S. J., Gallo, R. C., & Gallagher, R. E. (1977) · Nature · doi:10.1038/270347a0 · Cited by 2,124
Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia
Foley, G. E., Lazarus, H., Farber, S., Geren, B. B., Boone, B. A., & McCarthy, R. E. (1965) · Cancer · doi:10.1002/1097-0142(196504)18:4 · Cited by 1,166
Schneider, U., Schwenk, H. U., & Bornkamm, G. W. (1977) · International Journal of Cancer · doi:10.1002/ijc.2910190505 · Cited by 730
HeLa cells 50 years on: the good, the bad and the ugly
Masters, J. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc775 · Cited by 560
Short tandem repeat profiling provides an international reference standard for human cell lines
Masters, J. R., Thomson, J. A., Daly-Burns, B., Reid, Y. A., Dirks, W. G., Packer, P., Toji, L. H., Ohno, T., Tanabe, H., Arlett, C. F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121616198 · Cited by 478
Self-citationMenézes, J., Leibold, W., Klein, G., & Clements, G. R. (1975) · PubMed · Cited by 387
Human cancer cell lines: fact and fantasy
Masters, J. R. W. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043102 · Cited by 352
Research works printed but not linked: 5
- ISCN. Mitelman F (ed). An International System for Human Chromosome Nomenclature, S Karger: Basel 1995.
- Galili N, Galili U, Ravid Z, Schlesinger M, Goldblum N . Induction of differentiation with phorbol ester in a human T cell line (Be13) expressing both prothymocyte and thymocyte characteristics. Human Lymph Diff 1981; 1: 123–130.
- Pirruccello SJ, Lang MS, Sanger WG . PBEI: A pre-B acute lymphoblastic leukemia cell line derived from long term bone marrow culture. Blood 1991; 78: 39a.
- Drexler HG, Dirks WG, MacLeod RAF, Quentmeier H, Steube KG, Uphoff CC (eds). DSMZ Catalogue of Human and Animal Cell Lines, 8th edn, DSMZ: Braunschweig, Germany (2001.
- Moore GE, Woods LK, Minowada J, Mitchen JR . Establishment of leukemia cell line with T cell characteristics In Vitro. 1973; 8: 434.
Cited by
Sorted by citations
van Dongen, J. J. M., Langerak, A. W., Brüggemann, M., Evans, P., Hummel, M., Lavender, F. L., Delabesse, É., Davi, F., Schuuring, E. M. D., García‐Sánz, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403202 · Cited by 3,040
Gene expression perturbation in vitro—A growing case for three-dimensional (3D) culture systems
Birgersdotter, A., Sandberg, R., & Ernberg, I. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.06.009 · Cited by 591
Check your cultures! A list of cross‐contaminated or misidentified cell lines
Capes‐Davis, A., Theodosopoulos, G., Atkin, I., Drexler, H. G., Kohara, A., MacLeod, R. A. F., Masters, J. R., Nakamura, Y., Reid, Y. A., Reddel, R. R., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25242 · Cited by 520
Self-citationThe Costs of using Unauthenticated, Over-Passaged Cell Lines: How Much more Data do we Need?
Hughes, P., Marshall, D., Reid, Y., Parkes, H., & Gelber, C. (2007) · BioTechniques · doi:10.2144/000112598 · Cited by 434
Poynton, F. E., Bright, S. A., Blasco, S., Williams, D. C., Kelly, J. M., & Gunnlaugsson, T. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00680b · Cited by 430
Dighiero, G., & Hamblin, T. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60456-0 · Cited by 369
Cancer Cell Lines Are Useful Model Systems for Medical Research
Mirabelli, P., Coppola, L., & Salvatore, M. (2019) · Cancers · doi:10.3390/cancers11081098 · Cited by 346
Zhao, M., Sano, D., Pickering, C. R., Jasser, S. A., Henderson, Y. C., Clayman, G. L., Sturgis, E. M., Ow, T. J., Lotan, R., Carey, T. E., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0690 · Cited by 282
Cell line misidentification: the beginning of the end
American Type Culture Collection Standards Development Organization Workgroup ASN-0002 (2010) · Nature Reviews Cancer · doi:10.1038/nrc2852 · Cited by 266
Mohseny, A. B., Machado, I., Cai, Y., Schaefer, K., Serra, M., Hogendoorn, P. C. W., Llombart‐Bosch, A., & Cleton-Jansen, A. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.72 · Cited by 206
Astashkina, A. I., & Grainger, D. W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.02.008 · Cited by 200
van der Meer, D., Barthorpe, S., Yang, W., Lightfoot, H., Hall, C., Gilbert, J., Francies, H. E., & Garnett, M. J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky872 · Cited by 195
Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and Pitfalls
Hinson, A. R., Jones, R., Crose, L. E. S., Belyea, B., Barr, F. G., & Linardic, C. M. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00183 · Cited by 193
Match criteria for human cell line authentication: Where do we draw the line?
Capes‐Davis, A., Reid, Y. A., Kline, M. C., Storts, D. R., Strauss, E., Dirks, W. G., Drexler, H. G., MacLeod, R. A. F., Sykes, G., Kohara, A., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27931 · Cited by 180
“29 Thus to interpret authentication test results correctly, one must use standardized match criteria to discriminate between ‘‘related’’ (same donor) and ‘‘unrelated’’ (different donor) samples, with some allowance for genetic drift.”
MethodSelf-citationHigh‐throughput SNP‐based authentication of human cell lines
Castro, F., Dirks, W. G., Fähnrich, S., Hotz‐Wagenblatt, A., Pawlita, M., & Schmitt, M. (2013) · International Journal of Cancer · doi:10.1002/ijc.27675 · Cited by 183
Self-citationThe RAC1 P29S Hotspot Mutation in Melanoma Confers Resistance to Pharmacological Inhibition of RAF
Watson, I. R., Li, L., Cabeceiras, P. K., Mahdavi, M., Gutschner, T., Genovese, G., Wang, G., Fang, Z., Tepper, J. M., Stemke‐Hale, K., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1232-t · Cited by 173
Sandberg, R., & Ernberg, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408105102 · Cited by 170
The ghosts of HeLa: How cell line misidentification contaminates the scientific literature
Horbach, S. P. J. M., & Halffman, W. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186281 · Cited by 167
Human primary bronchial lung cell constructs: The new respiratory models
BéruBé, K., Prytherch, Z. C., Job, C., & Hughes, T. (2010) · Toxicology · doi:10.1016/j.tox.2010.04.004 · Cited by 158
A map of gene expression in neutrophil-like cell lines
Rincón, E., Rocha-Gregg, B. L., & Collins, S. R. (2018) · BMC Genomics · doi:10.1186/s12864-018-4957-6 · Cited by 160
Studying Neutrophil Function in vitro: Cell Models and Environmental Factors
Blanter, M., Gouwy, M., & Struyf, S. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s284941 · Cited by 160
Persistent use of “false” cell lines
Lacroix, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23233 · Cited by 151
Ye, F., Chen, C., Qin, J., Liu, J., & Zheng, C. (2015) · The FASEB Journal · doi:10.1096/fj.14-266718 · Cited by 144
High-throughput detection and multiplex identification of cell contaminations
Schmitt, M., & Pawlita, M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp581 · Cited by 142
Reproducibility: changing the policies and culture of cell line authentication
Freedman, L. P., Gibson, M. C., Ethier, S. P., Soule, H. R., Neve, R. M., & Reid, Y. A. (2015) · Nature Methods · doi:10.1038/nmeth.3403 · Cited by 136
Prevention and detection of Mycoplasma contamination in cell culture.
Nikfarjam, L., & Farzaneh, P. (2012) · Europe PMC (PubMed Central) · Cited by 156
Cancer cell line identification by short tandem repeat profiling: power and limitations
Parson, W., Kirchebner, R., Mühlmann, R., Renner, K., Kofler, A., Schmidt, S., & Kofler, R. (2005) · The FASEB Journal · doi:10.1096/fj.04-3062fje · Cited by 129
Nagel, S., Kaufmann, M., Drexler, H. G., & MacLeod, R. A. F. (2003) · PubMed · Cited by 126
Self-citationEradication of cross-contaminated cell lines: A call for action
Nardone, R. M. (2007) · Cell Biology and Toxicology · doi:10.1007/s10565-007-9019-9 · Cited by 126
Phuchareon, J., Ohta, Y., Woo, J. M., Eisele, D. W., & Tetsu, O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006040 · Cited by 105
Dirks, W. G., MacLeod, R. A. F., Nakamura, Y., Kohara, A., Reid, Y., Milch, H., Drexler, H. G., & Mizusawa, H. (2010) · International Journal of Cancer · doi:10.1002/ijc.24999 · Cited by 104
Self-citationArya, S. B., Chen, S., Jordan-Javed, F., & Parent, C. A. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00934-8 · Cited by 101
Sources of error in the retracted scientific literature
Casadevall, A., Steen, R. G., & Fang, F. C. (2014) · The FASEB Journal · doi:10.1096/fj.14-256735 · Cited by 89
Trials, Tribulations, and Trends in Tumor Modeling in Mice
Schuh, J. C. L. (2004) · Toxicologic Pathology · doi:10.1080/01926230490424770 · Cited by 86
Way, G. P., Zietz, M., Rubinetti, V., Himmelstein, D. S., & Greene, C. S. (2020) · Genome biology · doi:10.1186/s13059-020-02021-3 · Cited by 76
https://www.altex.org/index.php/altex/article/view/1339
Krebs, A., Waldmann, T., Wilks, M. F., van Vugt-Lussenburg, B. M. A., van der Burg, B., Terron, A., Steger-Hartmann, T., Ruegg, J., Rovida, C., Pedersen, E., et al. (2019) · ALTEX · doi:10.14573/altex.1909271 · Cited by 77
Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research
Skopek, R., Palusińska, M., Kaczor-Keller, K. B., Pingwara, R., Papierniak, A., Schenk, T., Lewicki, S., Zelent, A., & Szymański, Ł. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065377 · Cited by 81
Neutrophil-generated HOCl leads to non-specific thiol oxidation in phagocytized bacteria
Degrossoli, A., Müller, A., Xie, K., Schneider, J. F., Bader, V., Winklhofer, K. F., Meyer, A. J., & Leichert, L. I. O. (2018) · eLife · doi:10.7554/elife.32288 · Cited by 66
Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines
Vishwanatha, J. K., Salazar, E., & Gopalakrishnan, V. K. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-8 · Cited by 67
Fusenig, N. E., Capes-Davis, A., Bianchini, F., Sundell, S., & Lichter, P. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2001438 · Cited by 66
SK‐NEP‐1 and Rh1 are Ewing family tumor lines
Smith, M. A., Morton, C. L., Phelps, D. A., Girtman, K., Neale, G. A. M., & Houghton, P. J. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.21099 · Cited by 65
Molecular Characterization of Putative Chordoma Cell Lines
Brüderlein, S., Sommer, J., Meltzer, P. S., Li, S., Osada, T., Ng, D., Mӧller, P., Alcorta, D. A., & Kelley, M. J. (2010) · Sarcoma · doi:10.1155/2010/630129 · Cited by 65
Dirks, W. G., Fähnrich, S., Estella, I. A. J., & Drexler, H. G. (2005) · PubMed · Cited by 64
Self-citationMolecular and Functional Characterization of Hv1 Proton Channel in Human Granulocytes
Petheö, G. L., Orient, A., Baráth, M., Kovács, I. A., Réthi, B., Lányi, Á., Rajki, A., Rajnavölgyi, É., & Geiszt, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014081 · Cited by 63
Human Biosample Authentication Using the High-Throughput, Cost-Effective SNPtraceTM System
Liang-Chu, M. M. Y., Yu, M., Haverty, P. M., Koeman, J., Ziegle, J., Lee, M., Bourgon, R., & Neve, R. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116218 · Cited by 62
The CD24 surface antigen in neural development and disease
Gilliam, D. T., Menon, V., Bretz, N. P., & Pruszak, J. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.011 · Cited by 62
Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations
Drexler, H. G., Quentmeier, H., & MacLeod, R. A. F. (2003) · Leukemia · doi:10.1038/sj.leu.2403236 · Cited by 61
Self-citationDielectrophoresis-based microfluidic platforms for cancer diagnostics
Chan, J. Y., Kayani, A. B. A., Ali, M. A. M., Kok, C. K., Majlis, B. Y., Hoe, S. L. L., Marzuki, M., Khoo, A. S. B., Ostrikov, K., Rahman, M. A., et al. (2018) · Biomicrofluidics · doi:10.1063/1.5010158 · Cited by 59
WANG, H. J., Huang, S., Shou, J., Su, E. W., Onyia, J. E., Liao, B., & Li, S. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-166 · Cited by 58
STR DNA Typing of Human Cell Lines: Detection of Intra- and Interspecies Cross-Contamination
Dirks, W. G., & Drexler, H. G. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-128-8_3 · Cited by 57
Self-citationCytogenetic harvesting of commonly used tumor cell lines
MacLeod, R. A. F., Kaufmann, M., & Drexler, H. G. (2007) · Nature Protocols · doi:10.1038/nprot.2007.29 · Cited by 55
Self-citationMacLeod, R. A. F., Nagel, S., Kaufmann, M., Janssen, J. W. G., & Drexler, H. G. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10194 · Cited by 56
Self-citationWASP integrates substrate topology and cell polarity to guide neutrophil migration
Brunetti, R. M., Kockelkoren, G., Raghavan, P., Bell, G. R. R., Britain, D., Puri, N., Collins, S. R., Leonetti, M. D., Stamou, D. G., & Weiner, O. D. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202104046 · Cited by 52
Yang, J., Jin, L., Kim, H. S., Tian, F., Yi, Z., Bedi, K., Ljungman, M. E., di Magliano, M. P., Crawford, H. C., & Shi, J. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0968 · Cited by 55
CD38 in Hairy Cell Leukemia Is a Marker of Poor Prognosis and a New Target for Therapy
Poret, N., Fu, Q., Guihard, S., Cheok, M. H.-C., Miller, K., Zeng, G. G., Quesnel, B., Troussard, X., Galiègue‐Zouitina, S., & Shelley, C. S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0893 · Cited by 52
U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma
Mader, A., Brüderlein, S., Wegener, S., Melzner, I., Popov, S., Müller‐Hermelink, H. K., Barth, T. F. E., Viardot, A., & Mӧller, P. (2007) · Cytogenetic and Genome Research · doi:10.1159/000112062 · Cited by 51
Corral-Vázquez, C., Aguilar-Quesada, R., Catalina, P., Lucena-Aguilar, G., Ligero, G., Miranda, B., & Carrillo-Ávila, J. A. (2017) · Cell and Tissue Banking · doi:10.1007/s10561-017-9617-6 · Cited by 47
Steevels, T. A. M., Avondt, K. V., Westerlaken, G. H. A., Stalpers, F., Walk, J., Bont, L., Coffer, P. J., & Meyaard, L. (2013) · European Journal of Immunology · doi:10.1002/eji.201242916 · Cited by 46
T-Cell Transformation and Oncogenesis by γ2-Herpesviruses
Ensser, A., & Fleckenstein, B. (2005) · Advances in cancer research · doi:10.1016/s0065-230x(05)93003-0 · Cited by 46
Rücker, F. G., Sander, S., Döhner, K., Döhner, H., Pollack, J. R., & Bullinger, L. (2006) · Leukemia · doi:10.1038/sj.leu.2404235 · Cited by 45
Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia
Zebisch, A., Wölfler, A., Fried, I., Wolf, O., LIND, K., Bodner, C., Haller, M., Drasche, A., Pirkebner, D., Matallanas, D., et al. (2012) · Leukemia · doi:10.1038/leu.2012.61 · Cited by 43
Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM
Yin, W., Rossin, A., Clifford, J. L., & Gronemeyer, H. (2006) · Oncogene · doi:10.1038/sj.onc.1209410 · Cited by 43
Sandberg, Y., Verhaaf, B., van Gastel-Mol, E. J., Wolvers-Tettero, I. L. M., de Vos, J., MacLeod, R. A. F., Noordzij, J. G., Dik, W. A., van Dongen, J. J. M., & Langerak, A. W. (2006) · Leukemia · doi:10.1038/sj.leu.2404486 · Cited by 42
Self-citationFalse and mycoplasma-contaminated leukemia-lymphoma cell lines: time for a reappraisal
Drexler, H. G., Dirks, W. G., MacLeod, R. A. F., & Uphoff, C. C. (2017) · International Journal of Cancer · doi:10.1002/ijc.30530 · Cited by 45
Self-citationTabrizi, M. A., Shamsipur, M., Saber, R., & Sarkar, S. (2017) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.07.054 · Cited by 41
Santiago, T., Викторович, К. С., Reshetnikova, E. S., Chikaev, N. A., Volkova, O. Y., Мечетина, Л. В., Zhao, M., Davis, R. S., Taranin, A. V., Najakshin, A. M., et al. (2010) · International Immunology · doi:10.1093/intimm/dxq456 · Cited by 40
Visco, C., Novella, E., Peotta, E., Paolini, R., Giaretta, I., & Rodeghiero, F. (2010) · Haematologica · doi:10.3324/haematol.2010.022079 · Cited by 37
Ahmad, S. M., Svane, I. M., & Andersen, M. H. (2014) · Blood Cancer Journal · doi:10.1038/bcj.2014.50 · Cited by 35
Malignant hematopoietic cell lines: in vitro models for the study of erythroleukemia
Drexler, H. G., Matsuo, Y., & MacLeod, R. A. F. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.03.022 · Cited by 34
Self-citationCharacterization and authentication of cancer cell lines: an overview
Reid, Y. A. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-080-5_4 · Cited by 34
Genomic Landscape of Hodgkin Lymphoma
Brune, M. M., Juškevičius, D., Haslbauer, J. D., Dirnhofer, S., & Tzankov, A. (2021) · Cancers · doi:10.3390/cancers13040682 · Cited by 33
Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines
Beesley, A. H., Palmer, M.-L., Ford, J., Weller, R. E., Cummings, A. J., Freitas, J. R., Firth, M. J., Perera, K. U., de Klerk, N. H., & Kees, U. R. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603447 · Cited by 33
Atayar, Ç., Kok, K., Kluiver, J. L., Bosga-Bouwer, A., van den Berg, E., van der Vlies, P., Blokzijl, T., Harms, G., Davelaar, I., Sikkema‐Raddatz, B., et al. (2006) · Human Pathology · doi:10.1016/j.humpath.2006.01.018 · Cited by 33
Hallberg, L. A. E., Barlous, K., & Hawkins, C. L. (2023) · Antioxidants · doi:10.3390/antiox12020478 · Cited by 34
Bhakta, S. B., Lundgren, S. M., Sesti, B. N., Flores, B. A., Akdoğan, E., Collins, S. R., & Mercer, F. K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297758 · Cited by 32
Seiser, E., Thomas, R. J., Richards, K. L., Kelley, M. K., Moore, P. F., Suter, S. E., & Breen, M. (2011) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2011.00299.x · Cited by 32
A bioinformatics analysis of the cell line nomenclature
Sarntivijai, S., Ade, A. S., Athey, B. D., & States, D. J. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn502 · Cited by 32
Hodgkin lymphoma cell lines: to separate the wheat from the chaff
Drexler, H. G., Pommerenke, C., Eberth, S., & Nagel, S. (2018) · Biological Chemistry · doi:10.1515/hsz-2017-0321 · Cited by 32
Self-citationGomes, M. T., Palasiewicz, K., Gadiyar, V., Lahey, K. C., Calianese, D. C., Birge, R. B., & Ucker, D. S. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102034 · Cited by 36
Hahn, M. M., & Gunn, J. S. (2020) · Microorganisms · doi:10.3390/microorganisms8020253 · Cited by 31
Khosravi, A., Khoshnia, M., Kazeminejad, V., & Asadi, J. (2015) · Tumor Biology · doi:10.1007/s13277-015-4133-4 · Cited by 30
Disparities in Cisplatin-Induced Cytotoxicity—A Meta-Analysis of Selected Cancer Cell Lines
Ćwiklińska-Jurkowska, M. M., Wiese‐Szadkowska, M., Janciauskiene, S. M., & Paprocka, R. (2023) · Molecules · doi:10.3390/molecules28155761 · Cited by 31
Dancik, G. M., Ru, Y., Owens, C. R., & Theodorescu, D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2427 · Cited by 29
Rapid viscoelastic changes are a hallmark of early leukocyte activation
Zak, A., Merino-Cortés, S. V., Sadoun, A., Mustapha, F., Babataheri, A., Dogniaux, S., Dupré‐Crochet, S., Hudik, E., He, H., Barakat, A. I., et al. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.02.042 · Cited by 28
Database of misidentified cell lines
Freshney, R. I. (2009) · International Journal of Cancer · doi:10.1002/ijc.24998 · Cited by 28
Cell line cross-contamination in biomedical research: a call to prevent unawareness
Armando Rojas, R., González, I., & FIGUEROA, H. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00809.x · Cited by 27
Leukemia-lymphoma cell lines as model systems for hematopoietic research
Drexler, H. G., & MacLeod, R. A. F. (2003) · Annals of Medicine · doi:10.1080/07853890310012094 · Cited by 26
Self-citationMrózek, K., Tanner, S. M., Heinonen, K., & Bloomfield, C. D. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10274 · Cited by 26
Ellison, M. A., Gearheart, C. M., Porter, C. C., & Ambruso, D. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185956 · Cited by 25
Karpova, M. B., Schoumans, J., Blennow, E., Ernberg, I., Henter, J., Смирнов, А. Ф., Nordenskjöld, M., & Fadeel, B. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.3.605 · Cited by 24
JKT‐1 is not a human seminoma cell line
de Jong, J., Stoop, H., Gillis, A., van Gurp, R. J. H. L. M., van Drunen, E., Beverloo, H. B., Lau, Y. C., Schneider, D. T., Sherlock, J. K., Baeten, J., et al. (2007) · International Journal of Andrology · doi:10.1111/j.1365-2605.2007.00802.x · Cited by 23
Serglycin participates in retention of α-defensin in granules during myelopoiesis
Glenthøj, A. B., Cowland, J. B., Heegaard, N. H. H., Larsen, M. T., & Borregaard, N. (2011) · Blood · doi:10.1182/blood-2011-06-362947 · Cited by 21
Large-Scale Protein Profiling in Human Cell Lines Using Antibody-Based Proteomics
Fagerberg, L., Strömberg, S., El‐Obeid, A., Gry, M., Nilsson, K., Uhlén, M., Pontén, F., & Asplund, A. (2011) · Journal of Proteome Research · doi:10.1021/pr200259v · Cited by 21
Cell line misidentification: the beginning of the end
Masters, J. R. W. (2010) · UCL Discovery (University College London) · Cited by 20
Persistent Use of False Myeloma Cell Lines
Drexler, H. G., Matsuo, Y., & MacLeod, R. A. F. (2003) · Human Cell · doi:10.1111/j.1749-0774.2003.tb00140.x · Cited by 20
Self-citationPenas, E. M. M., Schilling, G., Behrmann, P., Klokow, M., Vettorazzi, E., Bokemeyer, C., & Dierlamm, J. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22161 · Cited by 20
Yin, W., Raffelsberger, W., & Gronemeyer, H. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.03.003 · Cited by 20
Gué, M., Sun, J., & Boudier, T. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-20 · Cited by 19
Wrona, D., Siler, U., & Reichenbach, J. (2017) · Scientific Reports · doi:10.1038/srep44187 · Cited by 18
Identification and verification of rodent cell lines by polymerase chain reaction
Steube, K. G., Koelz, A.-L., & Drexler, H. G. (2007) · Cytotechnology · doi:10.1007/s10616-007-9106-z · Cited by 18
Self-citation
Metadata
- Authors
- Drexler, H. G., Dirks, W. G., Matsuo, Y., & MacLeod, R. A. F.
- Affiliations
- Leibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures (DE)
- Hayashibara (Japan) (JP)
- Venue
- Leukemia
- Published
- 2003-02-01
- Volume
- 17
- Issue
- 2
- Pages
- 416-426
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2095077052
- Cited by
- 202
- References
- 115
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 4 · 2023: 10 · 2022: 7 · 2021: 8 · 2020: 11 · 2019: 5 · 2018: 9 · 2017: 10 · 2016: 5 · 2015: 9 · 2014: 11 · 2013: 4 · 2012: 12
- FWCI
- 13.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Leukemia (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- leukemia-lymphoma cell lines, cross-contamination, cell line authentication, DNA fingerprinting, cytogenetic evaluation, misidentification, misclassification, CCRF-CEM cells, HL-60 cells, Jurkat, K562 cells, U937 cells
- MeSH terms
- Humans, Karyotyping, Leukemia, Lymphoma, Research, Tumor Cells, Cultured, Reproducibility of Results, DNA Fingerprinting, Microsatellite Repeats, Cell Lineage
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review